Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture.

Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L.

Eur J Pharmacol. 2006 Apr 24;536(1-2):38-46. Epub 2006 Feb 28.

PMID:
16564524
2.

Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action.

Cortizo AM, Molinuevo MS, Barrio DA, Bruzzone L.

Int J Biochem Cell Biol. 2006;38(7):1171-80. Epub 2006 Jan 9.

PMID:
16455285
3.

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.

Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T.

Biochem Biophys Res Commun. 2008 Oct 24;375(3):414-9. doi: 10.1016/j.bbrc.2008.08.034. Epub 2008 Aug 20.

PMID:
18721796
4.

Vanadate-induced nitric oxide production: role in osteoblast growth and differentiation.

Cortizo AM, Caporossi M, Lettieri G, Etcheverry SB.

Eur J Pharmacol. 2000 Jul 21;400(2-3):279-85.

PMID:
10988345
5.

Nitric oxide modulates osteoblastic differentiation with heme oxygenase-1 via the mitogen activated protein kinase and nuclear factor-kappaB pathways in human periodontal ligament cells.

Lee SK, Choi HI, Yang YS, Jeong GS, Hwang JH, Lee SI, Kang KH, Cho JH, Chae JM, Lee SK, Kim YC, Kim EC.

Biol Pharm Bull. 2009 Aug;32(8):1328-34.

6.

A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.

Shin MK, Kim MK, Bae YS, Jo I, Lee SJ, Chung CP, Park YJ, Min do S.

Cell Signal. 2008 Apr;20(4):613-24. doi: 10.1016/j.cellsig.2007.11.012. Epub 2007 Nov 29.

PMID:
18248957
7.

Vanadyl(IV) complexes with saccharides. Bioactivity in osteoblast-like cells in culture.

Barrio DA, Cattáneo ER, Apezteguía MC, Etcheverry SB.

Can J Physiol Pharmacol. 2006 Jul;84(7):765-75.

PMID:
16998540
8.

Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells.

Gao Y, Xue J, Li X, Jia Y, Hu J.

J Pharm Pharmacol. 2008 Dec;60(12):1695-700. doi: 10.1211/jpp.60/12.0017.

PMID:
19000376
9.

Metformin reverses the deleterious effects of high glucose on osteoblast function.

Zhen D, Chen Y, Tang X.

J Diabetes Complications. 2010 Sep-Oct;24(5):334-44. doi: 10.1016/j.jdiacomp.2009.05.002. Epub 2009 Jul 22.

PMID:
19628413
10.

Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production.

Chang JK, Hsu YL, Teng IC, Kuo PL.

Eur J Pharmacol. 2006 Dec 3;551(1-3):1-9. Epub 2006 Sep 8.

PMID:
17026990
11.

Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2.

Jang WG, Kim EJ, Bae IH, Lee KN, Kim YD, Kim DK, Kim SH, Lee CH, Franceschi RT, Choi HS, Koh JT.

Bone. 2011 Apr 1;48(4):885-93. doi: 10.1016/j.bone.2010.12.003. Epub 2010 Dec 13.

PMID:
21147283
12.

Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.

Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C.

J Bone Miner Res. 2010 Feb;25(2):211-21. doi: 10.1359/jbmr.090732.

13.
14.

Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells.

Schurman L, McCarthy AD, Sedlinsky C, Gangoiti MV, Arnol V, Bruzzone L, Cortizo AM.

Exp Clin Endocrinol Diabetes. 2008 Jun;116(6):333-40. doi: 10.1055/s-2007-992786.

PMID:
18273753
15.

Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2.

Fan X, Rahnert JA, Murphy TC, Nanes MS, Greenfield EM, Rubin J.

J Cell Physiol. 2006 May;207(2):454-60.

PMID:
16419041
16.

Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway.

Hsu YL, Chang JK, Tsai CH, Chien TT, Kuo PL.

Biochem Pharmacol. 2007 Feb 15;73(4):504-14. Epub 2006 Oct 26.

PMID:
17113042
17.

Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats.

Sedlinsky C, Molinuevo MS, Cortizo AM, Tolosa MJ, Felice JI, Sbaraglini ML, Schurman L, McCarthy AD.

Eur J Pharmacol. 2011 Oct 15;668(3):477-85. doi: 10.1016/j.ejphar.2011.07.033. Epub 2011 Aug 5.

PMID:
21839072
18.

Nitroglycerin enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via nitric oxide pathway.

Huang L, Qiu N, Zhang C, Wei HY, Li YL, Zhou HH, Xiao ZS.

Acta Pharmacol Sin. 2008 May;29(5):580-6. doi: 10.1111/j.1745-7254.2008.00778.x.

19.

Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo.

Cornish J, Callon KE, Bava U, Watson M, Xu X, Lin JM, Chan VA, Grey AB, Naot D, Buchanan CM, Cooper GJ, Reid IR.

Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E117-22. Epub 2006 Aug 15.

20.

Nitric oxide mediates 17beta-estradiol-stimulated human and rodent osteoblast proliferation and differentiation.

O'Shaughnessy MC, Polak JM, Afzal F, Hukkanen MV, Huang P, MacIntyre I, Buttery LD.

Biochem Biophys Res Commun. 2000 Nov 2;277(3):604-10.

PMID:
11062001
Items per page

Supplemental Content

Write to the Help Desk